Ionis Pharmaceuticals Inc
(NAS:IONS)
$
38.77
0.35 (0.91%)
Market Cap: 6.11 Bil
Enterprise Value: 5.42 Bil
PE Ratio: 0
PB Ratio: 21.42
GF Score: 51/100 Ionis Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 12, 2021 / 07:30PM GMT
Release Date Price:
$37.31
(+1.69%)
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research
Good day, everybody. Thank you for joining the Bank of America Annual Healthcare Conference. My name is Jason Gerberry. I'm one of the biotech analysts at BofA. And I am pleased to be introducing our next company presenter, Ionis, and CFO, Beth Hougen. So Beth, thanks so much for joining us, first off, at the conference today.
Elizabeth L. Hougen
Ionis Pharmaceuticals, Inc. - Executive VP of Finance & CFO
Thank you. Thanks for having us. We're pleased to be here.
Questions & Answers
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research
Great. Great. So look, Ionis is one of the premier companies in the RNA space in terms of developing a platform, ASO platform. Maybe can you just set the stage in terms of how the company's capital allocation strategy and just broader strategy has changed in the last few years? The Sobi partnership is one example of a change. There's been messaging
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot